SCHEMBL703090

SCHEMBL703090

CCCC[Si](Cl)(CCCC)CC[Si](Cl)(CCCC)CCCC

nearest known ligand 0.38

Predicted protein targets (top 5)

geneUniProtsupporting neighboursconfidence
TSHR P16473 4/20 0.38
LMNA P02545 1/20 0.38
TDP1 Q9NUW8 1/20 0.37
THRB P10828 1/20 0.35
ALDH1A1 P00352 2/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL348204 0.97 TSHR (0.40) TSHRLMNATDP1THRBALDH1A1
Ammonia Solution, Strong SCHEMBL27832272 0.93 TSHR (0.38) TSHRLMNATDP1THRBALDH1A1
SCHEMBL704794 0.93 TSHR (0.38) TSHRLMNATDP1THRBALDH1A1
SCHEMBL706714 0.93 TSHR (0.38) TSHRLMNATDP1THRBALDH1A1
SCHEMBL3482229 0.90 TSHR (0.35) TSHRLMNATDP1THRBALDH1A1
SCHEMBL2273982 0.90 TSHR (0.35) TSHRLMNATDP1THRBALDH1A1
SCHEMBL25338689 0.88 TSHR (0.47) TSHRLMNATHRBALDH1A1
SCHEMBL18108495 0.88 TSHR (0.47) TSHRLMNATHRBALDH1A1
SCHEMBL7755459 0.88 TSHR (0.47) TSHRLMNATHRBALDH1A1
SCHEMBL18108168 0.88 TSHR (0.47) TSHRLMNATHRBALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-115605530-B Polycarbosilazanes and compositions comprising the same and methods of making silicon-containing films using the same 默克专利有限公司 2024-09-27 CN disclosed
US-11999827-B2 Polycarbosilazane, and composition comprising the same, and method for producing silicon-containing film using the same MERCK PATENT GMBH (DE) 2024-06-04 US disclosed
EP-4146725-B1 POLYCARBOSILAZANE, AND COMPOSITION COMPRISING THE SAME, AND METHOD FOR PRODUCING SILICON-CONTAINING FILM USING THE SAME MERCK PATENT GMBH (DE) 2024-05-22 EP disclosed
US-20230174724-A1 POLYCARBOSILAZANE, AND COMPOSITION COMPRISING THE SAME, AND METHOD FOR PRODUCING SILICON-CONTAINING FILM USING THE SAME MERCK PATENT GMBH (DE) 2023-06-08 US disclosed
CN-115605530-A Polycarbosilazanes, compositions comprising the same, and methods of making silicon-containing films using the same 默克专利有限公司(DE) 2023-01-13 CN disclosed
US-8124239-B2 Silica film forming material, silica film and method of manufacturing the same, multilayer wiring structure and method of manufacturing the same, and semiconductor device and method of manufacturing the same FUJITSU LIMITED (JP) 2012-02-28 US disclosed
US-8124636-B2 Imidazolidinone derivatives as 11B-HSD1 inhibitors HOFFMANN-LA ROCHE INC. (US) 2012-02-28 US disclosed
US-20100155121-A1 SILICA FILM FORMING MATERIAL, SILICA FILM AND METHOD OF MANUFACTURING THE SAME, MULTILAYER WIRING STRUCTURE AND METHOD OF MANUFACTURING THE SAME, AND SEMICONDUCTOR DEVICE AND METHOD OF MANUFACTURING THE SAME FUJITSU LIMITED (JP) 2010-06-24 US disclosed
US-7659357-B2 Precursor organosilicon polymer of 1,2-Bis(dimethylethoxysilyl)ethane, 1,4-bis(dimethylethoxysilyl)benzene, tetraethoxysilane, methyltriethoxysilane, phenyltriethoxysilane; dielectric (DE) films having etching/chemical/moisture resistance; adhesion; low DE constant; minimal wiring delay; high speed FUJITSU LIMITED (JP) 2010-02-09 US disclosed
US-20090275573-A1 Imidazolidinone Derivatives as 11B-HSD1 Inhibitors HOFFMANN-LA ROCHE, INC. 2009-11-05 US disclosed
US-20070026689-A1 Silica film forming material, silica film and method of manufacturing the same, multilayer wiring structure and method of manufacturing the same, and semiconductor device and method of manufacturing the same FUJITSU LIMITED (JP) 2007-02-01 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090275573-A1 Imidazolidinone Derivatives as 11B-HSD1 Inhibitors HSD11B1, HSD17B1, HSD17B11 TSHR 1734/4885LMNA 3111/4885TDP1 1007/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.